Abstract
The interleukin-2 pathway is essential for the normal immune response to antigen stimulation; we have examined the possibility that this may underlie abnormal peripheral blood lymphocyte immunoregulatory function that has been observed in patients with inflammatory bowel disease. We studied 11 patients with Crohn's disease and 5 with ulcerative colitis, all with quiescent disease activity. Peripheral blood mononuclear cells were isolated from these patients and from healthy age- and sex-matched controls. Interleukin-2 production after mitogen and phorbol-myristate acetate stimulation was similar in both groups: 381±71 (mean ± SE) U/ml by control cells and 451±70 by patient cells. Interleukin-2 receptor generation was also measured pre- and poststimulation by labeling with anti-Tac antibody. This was 10.45±1 and 69.95±3.85% for control cells and 11.41±1.38 and 60.9±4.25% for patients cells. Finally, we examined the response of these cells to interleukin-2 stimulation by generating cells with direct cytotoxicity to51Cr-labeled Daudi-cell targets. Control cells caused 59.5±46%51Cr release, whereas patient cells caused 50.8±5.18% release. None of the above results achieved statistical significance. We conclude that the peripheral blood interleukin-2 pathway is normal in inactive inflammatory bowel disease.
Similar content being viewed by others
References
Holdstock G, Chastenay BF, Krawitt EL: Increased suppressor cell activity in inflammatory bowel disease. Gut 22:1023–1030, 1981
Elson CO, Graeff AS, James ST, Strober W: Covert suppressor T-cells in Crohn's disease. Gastroenterology 81:1513–1521, 1981
Stevens R, Oliver M, Herserod J, Targan S: Defective generation of tetanus specific antibody productive B cells after in vivo immunization of Crohn's disease and ulcerative colitis patients. Gastroenterology 88:1860–1866, 1985
Kirsner JB, Shorter RG: Recent developments in nonspecific inflammatory bowel disease. N Engl J Med 306:837–848, 1983
Smith KA: Interleukin 2. Annu Rev Immunol 2:3129–3133, 1984
Ebert EC, Wright SH, Lipshutz WH, Hauptman SP: T-cell abnormalities in inflammatory bowel disease are moderate by interleukin 2. Clin Immunol Immunopathol 33:232–244, 1984
Fiocchi C, Hilfiber ML, Youngman KR, Doerder NC, Finke JH: Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease. Gastroenterology 86:734–741, 1984
Boyum AJ: Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest (Suppl 97) 21:77–89, 1968
Kappler JW, Skidmore B, White J, Marrack P: Antigen-inducible, H-2 restricted, interleukin-2-producing T cell hybridoma. J Exp Med 153:1198–1214, 1981
Turgut I, Gibbs D, Sibbit WL Jr, Bankhurst AD: Generation of natural killer cells and lymphokine-activated killer cells in human A-B serum or fetal bovine serum. Clin Immunol Immunopath 36:289–296, 1985
Fiocchi C, Youngman KR, Farmer RG: Immunoregulatory function of human intestinal mucosa lymphoid cells: Evidence for enhanced suppressor cell activity in inflammatory bowel disease. Gut 24:692–701, 1983
Raedler A, Franchel S, Klose G, Sylarth K, Thisle HG: Involvement of the immune system in the pathogenesis of Crohn's disease. Expression of the T9 antigen on peripheral immunocytes correlates with the severity of the disease. Gastroenterology 88:978–983, 1985
MacDermott RD, Bragdon MJ, Thrumon RD: Peripheral blood mononuclear cells from patients with inflammatory bowel disease exhibit normal function in the allogeneic and autologous mixed leukocyte reaction and cell mediated lympholysis. Gastroenterology 86:478–484, 1984
Auer LO, Roder A, Frohlich J: Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cells assays of lymphocyte proliferation and by enumeration of immunoregulatory T-lymphocyte subsets. Gastroenterology 86:1531–1543, 1984
Weiserbs D, Elson C: Abnormal T cell-T cell communication in the lesions of active Crohn's disease. Gastroenterology 84:1348 (A)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ming, R.H., Atluru, D., Spellman, C.W. et al. Peripheral blood mononuclear-cell interleukin-2 production, receptor generation and lymphokine-activated cytotoxicity in inflammatory bowel disease. J Clin Immunol 7, 59–63 (1987). https://doi.org/10.1007/BF00915426
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00915426